Supriya Lifescience (SUPRIYA) | Stock Overview & Key Data
Supriya Lifescience Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,085.00 on June 1, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Supriya Lifescience
SUPRIYA
|
51.74B Mid-cap | 3.93% | 38.73% | 66.47% | 32.20% | 28.93% | 41.71% | 283.42% | 102.02% | 102.02% | 102.02% | 102.02% |
|
Biocon
BIOCON
|
566.52B Large-cap | 1.66% | -3.27% | 10.34% | 6.50% | 7.30% | 17.90% | 71.09% | 5.03% | 250.57% | 603.49% | 1,357.39% |
|
OneSource Specialty
ONESOURCE
|
202.76B Large-cap | -6.58% | -11.52% | 8.72% | 0.44% | -9.19% | -20.38% | -5.70% | -5.70% | -5.70% | -5.70% | -5.70% |
|
Concord Biotech
CONCORDBIO
|
106.31B Mid-cap | 15.33% | 21.57% | 19.18% | 1.44% | 3.29% | -35.83% | 43.59% | 43.59% | 43.59% | 43.59% | 43.59% |
|
Blue Jet Healthcare
BLUEJET
|
69.97B Mid-cap | 11.86% | 17.17% | 41.50% | -8.00% | -4.67% | -46.26% | 31.46% | 31.46% | 31.46% | 31.46% | 31.46% |
|
Zota Health Care
ZOTA
|
39.41B Small-cap | 3.68% | 3.22% | 14.06% | -26.10% | -17.99% | 27.17% | 243.00% | 632.12% | 1,248.00% | 1,248.00% | 1,248.00% |
Ownership & Short Interest
Calculate Your Supriya Lifescience Investment Returns
Long-Term Investment Performance Analysis
Supriya Lifescience stock price in Dec 2021 was ₹483.70, A ₹1,000.00 lump sum investment in Supriya Lifescience made 4 years ago would be worth approximately ₹1,974.78 today, representing a solid return of 97.48%. This translates to an annualized return (CAGR) of 16.46%.
4 Years 5 Months Investment Scenario (Dec 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is SUPRIYA's 52-week high and low?
- In the last 52 weeks, Supriya Lifescience reached a high of ₹1,085.00 (on June 1, 2026) and a low of ₹545.50 (on March 24, 2026).
- What is the market cap and P/E ratio for SUPRIYA?
- Curious about Supriya Lifescience's size and valuation? Its market capitalization stands at 51.74B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.94, and the forward P/E (looking ahead) is 20.97.
- Does SUPRIYA pay dividends? If so, what's the yield?
- Yes, Supriya Lifescience is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.27%, and the company has paid an average of ₹0.80 per share annually over the past 3 years.
- Who are Supriya Lifescience's main competitors or similar companies to consider before investing?
When looking at Supriya Lifescience, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Biocon
BIOCON566.52B Healthcare Biotechnology 17.90% 71.09% OneSource Specialty
ONESOURCE202.76B Healthcare Biotechnology -20.38% -5.70% Concord Biotech
CONCORDBIO106.31B Healthcare Biotechnology -35.83% 43.59% Blue Jet Healthcare
BLUEJET69.97B Healthcare Biotechnology -46.26% 31.46% Zota Health Care
ZOTA39.41B Healthcare Biotechnology 27.17% 243.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Supriya Lifescience Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Supriya Lifescience's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 18.86%, the Debt to Equity ratio from the most recent quarter is 0.48, and its Gross Profit Margin stands at 70.35%.
- What is the recent revenue and earnings growth for SUPRIYA?
- Looking at Supriya Lifescience's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 11.20%, and quarterly earnings saw a YoY growth of 6.20%.
- How much of SUPRIYA stock is held by insiders and institutions?
- Wondering who owns Supriya Lifescience stock? Company insiders (like executives and directors) hold about 70.84% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.42%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.